Unknown

Dataset Information

0

?-Caryophyllene attenuates dextran sulfate sodium-induced colitis in mice via modulation of gene expression associated mainly with colon inflammation.


ABSTRACT: We examined the modulatory activity of ?-caryophyllene (CA) and gene expression in colitic colon tissues in a dextran sulfate sodium (DSS)-induced colitis model. Experimental colitis was induced by exposing male BALB/c mice to 5% DSS in drinking water for 7 days. CA (30 or 300 mg/kg) was administered orally once a day together with DSS. CA administration attenuated the increases in the disease activity index, colon weight/length ratio, inflammation score, and myeloperoxidase activity in DSS-treated mice. Microarray analysis showed that CA administration regulated the expression in colon tissue of inflammation-related genes including those for cytokines and chemokines (Ccl2, Ccl7, Ccl11, Ifitm3, IL-1?, IL-28, Tnfrsf1b, Tnfrsf12a); acute-phase proteins (S100a8, Saa3, Hp); adhesion molecules (Cd14, Cd55, Cd68, Mmp3, Mmp10, Sema6b, Sema7a, Anax13); and signal regulatory proteins induced by DSS. CA significantly suppressed NF-?B activity, which mediates the expression of a different set of genes. These results suggest that CA attenuates DSS-induced colitis, possibly by modulating the expression of genes associated mainly with colon inflammation through inhibition of DSS-induced NF-?B activity.

SUBMITTER: Cho JY 

PROVIDER: S-EPMC5598479 | biostudies-other | 2015

REPOSITORIES: biostudies-other

altmetric image

Publications

β-Caryophyllene attenuates dextran sulfate sodium-induced colitis in mice via modulation of gene expression associated mainly with colon inflammation.

Cho Jae Young JY   Kim Hwa Yeon HY   Kim Sung-Kyu SK   Park Jung Han Yoon JHY   Lee Hong Jin HJ   Chun Hyang Sook HS  

Toxicology reports 20150726


We examined the modulatory activity of β-caryophyllene (CA) and gene expression in colitic colon tissues in a dextran sulfate sodium (DSS)-induced colitis model. Experimental colitis was induced by exposing male BALB/c mice to 5% DSS in drinking water for 7 days. CA (30 or 300 mg/kg) was administered orally once a day together with DSS. CA administration attenuated the increases in the disease activity index, colon weight/length ratio, inflammation score, and myeloperoxidase activity in DSS-trea  ...[more]

Similar Datasets

| S-EPMC8399719 | biostudies-literature
| S-EPMC4848668 | biostudies-literature
| S-EPMC9822721 | biostudies-literature
| S-EPMC4524530 | biostudies-literature
| S-EPMC3667021 | biostudies-literature
| S-EPMC7756107 | biostudies-literature
| S-EPMC9536985 | biostudies-literature
| S-EPMC4008378 | biostudies-literature
| S-EPMC3299802 | biostudies-literature
| S-EPMC10372905 | biostudies-literature